Novo Nordisk A/SNVO

Novo Nordisk (est. 1923, Bagsvaerd, Denmark) researches, manufactures, and distributes pharmaceuticals across Europe, the Middle East, Africa, Asia, and North America. Operations span two units: Diabetes and Obesity Care—covering diabetes, obesity, and cardiovascular therapies—and Rare Disease, focusing on blood disorders, endocrine conditions, and hormone replacement. Beyond drugs, it produces insulin/growth hormone pens and digital diabetes management tools. It maintains strategic partnerships, including collaborations with UNICEF and Valo Health.